HCA Healthcare, Inc. (NYSE:HCA) Q2 2024 Results Conference Call July 23, 2024 10:00 AM ET
Company Participants
Frank Morgan - Vice President of Investor Relations
Sam Hazen - Chief Executive Officer
Mike Marks - Chief Financial Officer
Conference Call Participants
A.J. Rice - UBS
Ann Hynes - Mizuho Securities
Pito Chickering - Deutsche Bank
Brian Tanquilut - Jefferies
Ben Hendrix - RBC Capital Markets
Justin Lake - Wolfe Research
Whit Mayo - Leerink Partners
Andrew Mok - Barclays
Stephen Baxter - Wells Fargo
Scott Fidel - Stephens
Jason Cassorla - Citigroup
Kevin Fischbeck - Bank of America
Ryan Langston - TD Cowen
John Ransom - Raymond
Sarah James - Cantor Fitzgerald
Operator
Welcome to the HCA Healthcare Second Quarter 2024 Earnings Conference Call. Today's call is being recorded.
At this time, for opening remarks and introductions, I would like to turn the call over to Vice President of Investor Relations, Mr. Frank Morgan. Please go ahead, sir.
Frank Morgan
Good morning, and welcome to everyone on today's call. With me this morning is our CEO, Sam Hazen; and our CFO, Mike Marks. Sam and Mike will provide some prepared remarks, and then we'll take some questions.
Before I turn the call over to Sam, let me remind everyone that should today's call contain any forward-looking statements that are based on management's current expectations. Numerous risks, uncertainties and other factors may cause actual results to differ materially from those that might be expressed today. More information on forward-looking statements and these factors are listed in today's press release and in our various SEC filings.
On this morning's call, we may reference measures such as adjusted EBITDA, which is a non-GAAP financial measure. A table providing supplemental information on adjusted EBITDA and reconciling net income attributable to HCA is included in today's release. This morning's call is being recorded, and a replay of the call will be available later today.
With that, I'll now turn the call over to Sam.
Sam Hazen
All right. Thank you, Frank, and good morning to everyone. The Company's results for the second quarter were positive across the board and reflected strong demand for our services. In addition, our teams continue to execute our strategic plan effectively and produced positive outcomes for our patients, while also enhancing in our facilities, including better throughput and case management.
I want to thank our HCA colleagues for their outstanding work and their continued pursuits to innovate and deliver on our mission. As compared to the prior year, diluted earnings per share as adjusted increased 28% to $5.50. Consistent with the first quarter, we saw broad-based volume growth across our markets and service lines.